Skip to content
CancerIndex

Publication

PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma.

Anaïs Schavgoulidze, Jian Cui, Jessica Encinas Mayoral, Vanessa Favasuli, Srikanth Talluri, Sabrina Maheo, Chloé Cerutti, Masood Shammas, Daniel Primo, Carmen Vicente, Marta Larrayoz, José A Martínez-Climent, Kenneth C Anderson, Anil Aktas-Samur, Mehmet Kemal Samur, Hervé Avet-Loiseau, Jill Corre, Nikhil C Munshi, Mariateresa Fulciniti

BloodSep 17, 2026PMID 42237635doi:10.1182/blood.2026033819 PMC13598913Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 30, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260930-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Deletion of chromosome 17p [del(17p)] is among the most adverse cytogenetic abnormalities in multiple myeloma (MM). By integrating RNA sequencing data from cells of patients with MM with genetic dependency data from MM cell lines, we identified protein kinase membrane-associated tyrosine/threonine…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.